Role of the intestinal microbiota in treatment with cyclin-dependent kinase inhibitor drugs in metastatic breast cancer

Project objectives

• evaluate changes in the intestinal microbiota in patients treated with cyclin-dependent kinase inhibitors
• correlate the composition of the intestinal microbiota with toxicities from cyclin-dependent kinase inhibitors

Start and end date

Project Manager

Coordinating institution of the project

Other Institutions involved

• Analysis Laboratory, Campus Bio-Medico University Hospital Foundation